Endovascular thrombectomy and intravenous alteplase in patients with acute ischemic stroke due to large vessel occlusion: A clinical practice guideline

Whether or not use of intravenous alteplase in combination with endovascular thrombectomy (EVT) improves outcomes versus EVT alone, for acute stroke patients with large vessel occlusion presenting directly to a comprehensive stroke center, is uncertain.

[1]  Eric E. Smith,et al.  Cost-effectiveness of endovascular thrombectomy with alteplase versus endovascular thrombectomy alone for acute ischemic stroke secondary to large vessel occlusion , 2023, CMAJ open.

[2]  Eric E. Smith,et al.  Endovascular thrombectomy with or without intravenous alteplase for acute ischemic stroke due to large vessel occlusion: a systematic review and meta-analysis of randomized trials , 2022, Stroke and vascular neurology.

[3]  Ana Catarina Fonseca,et al.  European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion , 2022, Journal of NeuroInterventional Surgery.

[4]  L. Beenen,et al.  A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. , 2021, The New England journal of medicine.

[5]  P. Nichelli,et al.  Safety and Outcomes of Thrombectomy in Ischemic Stroke With vs Without IV Thrombolysis , 2021, Neurology.

[6]  G. Guyatt,et al.  GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings. , 2021, Journal of clinical epidemiology.

[7]  Ana Catarina Fonseca,et al.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke , 2021, European stroke journal.

[8]  P. Mordasini,et al.  Safety and efficacy of intra-arterial fibrinolytics as adjunct to mechanical thrombectomy: a systematic review and meta-analysis of observational data , 2021, Journal of NeuroInterventional Surgery.

[9]  T. Ueda,et al.  Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. , 2021, JAMA.

[10]  R. Nogueira,et al.  Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial. , 2021, JAMA.

[11]  Yongjun Wang,et al.  Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases , 2020, Stroke and vascular neurology.

[12]  A. Demchuk,et al.  Early Recanalization With Alteplase in Stroke Because of Large Vessel Occlusion in the ESCAPE Trial , 2020, Stroke.

[13]  Y. Zhou,et al.  Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. , 2020, The New England journal of medicine.

[14]  Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[15]  R. Sacco,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke. , 2019, Stroke.

[16]  P. Sylaja,et al.  Recommendations for the Early Management of Acute Ischemic Stroke: A Consensus Statement for Healthcare Professionals from the Indian Stroke Association , 2018, Journal of Stroke Medicine.

[17]  Michael D Hill,et al.  eTICI reperfusion: defining success in endovascular stroke therapy , 2018, Journal of NeuroInterventional Surgery.

[18]  Deepak L. Bhatt,et al.  Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials , 2018, Journal of Thrombosis and Thrombolysis.

[19]  K. Butcher,et al.  Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018 , 2018, International journal of stroke : official journal of the International Stroke Society.

[20]  M. Krause,et al.  Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke , 2018, The New England journal of medicine.

[21]  Adnan H Siddiqui,et al.  Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis. , 2016, JAMA.

[22]  H. Schünemann,et al.  Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines. , 2015, Annals of internal medicine.

[23]  Eric E. Smith,et al.  Drip and Ship Thrombolytic Therapy for Acute Ischemic Stroke: Use, Temporal Trends, and Outcomes , 2015, Stroke.

[24]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials , 2014, The Lancet.

[25]  G. Donnan,et al.  A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. , 2012, The New England journal of medicine.

[26]  G. Guyatt,et al.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency. , 2011, Journal of clinical epidemiology.

[27]  G. Guyatt,et al.  GRADE guidelines: 8. Rating the quality of evidence--indirectness. , 2011, Journal of clinical epidemiology.

[28]  G. Guyatt,et al.  GRADE guidelines: 5. Rating the quality of evidence--publication bias. , 2011, Journal of clinical epidemiology.

[29]  G. Guyatt,et al.  GRADE guidelines 6. Rating the quality of evidence--imprecision. , 2011, Journal of clinical epidemiology.

[30]  G. Guyatt,et al.  GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias). , 2011, Journal of clinical epidemiology.

[31]  G. Guyatt,et al.  GRADE guidelines: 3. Rating the quality of evidence. , 2011, Journal of clinical epidemiology.

[32]  J. Broderick.  Endovascular Therapy for Acute Ischemic Stroke , 2009, Stroke.

[33]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[34]  J. Grotta,et al.  Early stroke treatment associated with better outcome: the ninds rt-pa stroke study , 2000, Neurology.

[35]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[36]  S. Kohyama,et al.  Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke. , 2018, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[37]  R. Higashida,et al.  The PROACT II Study : A Randomized Controlled Trial Intra-arterial Prourokinase for Acute Ischemic Stroke : , 1999 .